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Procedure Success 
Device Success 
Any MACE’ 
Death 
Q-wave MI 
Non-Q wave MI# 
TVR (Surgical or percutaneous) 
Final TIM1 Flow 
92% (23/25) 
96% (24/25) 
8% (2/25) 
0% 
0% 
8% (2/25) 
4% (1125) 
2.8 * 0.7 (24) 
(0.0, 3.0) 
*Death, Q or Non-Q MI. Emergency TVR: #CK-MB > BXULN; TVR -target vessel 
revascularization 
Conclusions: This preliminary experience suggests that the novel low-profile Intercep- 
torTM filter wire appears safe and effective in reducing atheroembolism during stenting of 
complex SVG stenoses. A randomized trial comparison with approved standard is 
planned. 
1005A-213 Hemoglobin Level Is an Independent Predictor of 
Mortality in Patients Undergoing Percutaneous 
Coronary Artery Interventions 
Hitinder S. Gurm, Ritesh Gupta, Michael S. Lauer, Russel Raymond, Stephen G. Ellis, 
The Cleveland Clinic Foundation, Cleveland. OH 
Background: Anemia is a powerful predictor of mortality in patients with congestive heart 
failure. The significance of anemia in patients with coronary artery disease is unknown. 
Methods: We studied 4309 patients undergoing percutaneous coronary intervention 
(PCI) from October 1996 to August 2001 stratified by their pre-procedural hemoglobin 
levels into quartiles. There were 1051 patients in 1 St quartile (mean lib 10.80, range 6.7. 
12.0g/dl), 1077 in 2”d quartile (mean Hb 12.75 g/dl, range 12.1.13.39/dl), 1135 in the 3” 
quartile (mean Hb 13.93 gldl, range 13.4-14.5 g/dl), and 1046 patients in the 4’“quartile 
(mean Hb15.37 g/dl, range 14.6-18.0 g/dl). Patients were followed for a median of 3 
years after the PCI. Results: There were 228 (22%) deaths in the 1 J’quactile, 116 (11%) 
deaths in the 2ti quartile, 75 (7%) deaths in the 9 quartile, and 61 (6%) deaths in the 
4’h quartile. An increase of 1 gmJdl in pre-procedural Hb level was associated with a sig- 
nificant reduction in hazard rate of death after PCI (hazard ratio 0.70, 95%CI 0.67 to 
0.74, p<O.OOl). The association remained strong after adjusting for age, gender, white 
blood cell count, serum creatinine, left ventricular ejection fraction, acute myocardial inf- 
arction, diabetes, ACC lesion score, adjunct medications and site of lesion (HR 0.841. 
95% Cl 0.79 - 0.89, p ~0.001) Conclusion: A lower pre-procedural Hb level, even in the 
range considered to be normal. is associated with increased long-term mortality in 
patients undergoing PCI. 
1005A-214 Does Coronary Angioplasty Lead to Accelerated 
Progression of Non-Critical Corsnary Artery Stenoses? 
Zaza J. Aivazi, Lev Lubarsky. Anastasia Nikitina, Milena G. Adamian, Ali Aboufares. 
Eugene C. DePasquale, Julia Adamian, Yelena Pertsovsky, Jeffrey Moses, Neil Coplan, 
lssam Moussa, Lenox Hill Hospital, New York, NY 
Background: It has been suggested that coronary intervention may provoke progression 
in non-critical stenoses due to wire trauma or unintended manipulation. This study was 
performed to determine whether index coronary allery intewention leads to accelerated 
progression of non-critical coronary disease. 
Methods: The study included 90 pts with 186 non-critical coronary artery stenoses 
(diameter stenosis, DS ~50%) that had paired angiograms separated by more than 6 
months. Non-critical stenoses were divided into two groups: Group I - stenosis located in 
the angioplasted arteries (n=51) and Group II - stenosis located in a non-culprit arteries 
(n=135). Angiographic analysis was performed using the MEDIS-QCA-CMS system. Dis- 
ease progression was defined as an increase in DS by z-15%. 
Results: Pts mean age was 6k_12 yrs and 77% were males. Diabetes and hyperlipe- 
demia were present in 37% and 79%, respectively. The paired angiograms were sepa- 
rated by a mean of 8+2 months. Baseline DS was 3&l 1% and at follow-up increased to 
38~13%. Significant progression occurred in 30 stenoses (16%) with a mean change in 
DS of 21+6%. Disease progression was independent of tobacco, diabetes, or hyperlipe- 
demia. 
Comparison of Groups I and II is shown: 
Group I(n=51) Group II P value 
(n=135) 
Progression 9 (18%) 21 (16%) NS 
Mean change in DS (%) 23+s 219 NS 
‘Conclusion: Progression of non-critical coronary disease occurs in a minority of 
stenoses 8 months after angioplasty. Index intervention did not lead to accelerated dis- 
ease progression in manipulated coronary arteries compared to other atteries. 
1005A-215 Baseline Plasma Creatinine Is an Independent Predictor 
of In-Hospital Mortality After Percutaneous Coronary 
Intervention 
Vladimir Dzavik. Cynthia Jackevicius, Steven Miner, Alan Barolet. Karen Mackie, John 
Ross, Peter Seidelin, Toronto General Hospital, Toronto, ON, Canada 
Background: Patients with established renal failure (RF) are at an increased risk of 
adverse events and mortality following percutaneous coronary interventions (PCI). The 
outcome in those with mild RF is less clear. The main aim of this study was to determine 
the rates of in-hospital events after PCI in patients with normal renal function, mild RF 
and moderate to severe RF. Secondly we sought to determine if plasma creatinine at 
baseline is an independent predictor of in-hospital adverse outcome after PCI. Methods: 
We analyzed all consecutive PCI cases performed at the Toronto General Hospital 
between April 1. 2001 and March 30. 2002 and entered into a prospective database. 
Patients were divided into 3 groups: baseline serum creatinine (Cr) 180umoUl (Group C). 
The in-hospital outcomes for each subgroup were compared and independent predictors 
of death were determined by multiple regression analysis. Results: A total of 2011 PCI 
cases were performed. There were 1772 subjects in Group A (mean age 62*1 lyrs). 152 
subjects in Group B (68+lOyrs) and 86 subjects in Group C (68+12yrs). In-hospital mor- 
tality was 0.8%, 5.9% and 7.0% in groups A, B and C respectively (pcO.0001); mortality. 
myocardial infarction (MI) and abrupt closure (AC) occurred in 3.0%, 6.6% and 10.5% of 
patients in Groups A, Band C respectively (p=O.o002). Prior Ml (pcO..OOOl), case acuity 
(p<O.OOOl), age (p<O.OOOl) baseline creatinine (p=.OOO2), and diabetes (p=O.OOS) were 
identified as independent predictors of in-hospital mortality following PCI. 
Conclusion: Baseline renal function is a powerful independent predictor of in-hospital 
mortality and other adverse events after PCI. Even mild elevation in baseline serum cre- 
atinine is associated with a substantial increase in mortality risk. This should be taken 
into account by the intewentional cardiologist when considering a patient for a percuta- 
neous coronary interventional procedure. 
1005A-2 16 International Trends in the Use of Primary 
Percutaneous Coronary Intervention 
Mark J. Eisenberg, Kristian B. Filion, Abigail Moreland, Olga Saynina, Louise Pilate, For 
the TECH Investigators. Jewish General Hospital/McGill University, Montreal, PO, 
Canada 
Background: Primary percutaneous coronary intervention (PCI) is an effective treatment 
for acute myocardial infarction (AMI). However, little is known about international trends 
in the use of this technology. 
Objective: To examine international trends in the use of primary PCI. 
Methods: National databases and large regional databases were used to examine 
aggregate data for AMI patients from 5 countries (Canada, Denmark, England, Sweden, 
and the United States (U.S.)), with data covering the period of 1990-1999. Data were 
standardized for age and sex using the 1995 United States AMI patient cohort. 
Results: We found that, in all countries, patients receiving primary PCI were younger 
and more likely to be male compared to AMI patients not receiving PCI. The use of pri- 
mary PCI varied widely with the highest use in the U.S. (12.4% among AMI patients < 65 
years old in California; 6.9% among U.S. Medicare AMI patients 265 years old) and the 
lowest in England (0.3% of all AMI patients). The U.S., with the earliest start and most 
rapid growth in primary PCI usage, were the international leaders in primary PCI use 
(Table). In most countries, patients receiving primaly PCI had lower in-hospital mortality 
rates and, in all countries, they had shorter lengths of stay. Lower mortality rates and 
shorter lengths of stay among primary PCI patients were maintained at 90 days post- 
AMI. 
Conclusions: Important international variations exist in the use of primary PCI. 
